Relationship between PLR and Clinicopathological Characteristics of Patients with Advanced NSCLC and Its Predictive Value for the Efficacy of Chemotherapy and Prognosis

Relationship between PLR and Clinicopathological Characteristics of Patients with Advanced NSCLC and Its Predictive Value for the Efficacy of Chemotherapy and Prognosis

Objective. To investigate the relationship between blood platelet-to-lymphocyte ratio (PLR) and clinicopathological characteristics of patients with advanced non-small cell lung cancer (NSCLC) and evaluate the value of PLR for predicting the efficacy of chemotherapy and prognosis. Methods. The clini...

Full description

Saved in:

Bibliographic Details
Main Authors:	Jianming Zhao, Yiping Pan, Yu Sheng, Jun Sun
Format:	Article
Language:	English
Published:	Wiley 2022-01-01
Series:	Emergency Medicine International
Online Access:	http://dx.doi.org/10.1155/2022/5811219
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

OPN Polymorphism Is Related to the Chemotherapy Response and Prognosis in Advanced NSCLC
by: Yanzhang Hao, et al.
Published: (2014-01-01)

Significance of EGFR and PTEN Expression and PLR and NLR for Predicting the Prognosis of Epithelioid Malignant Peritoneal Mesothelioma
by: Yufei Liang, et al.
Published: (2019-01-01)

The Relationship Between Clinicopathological Features and Prognosis of 22 Cases of Tubular Breast Carcinoma
by: Lin Tian, et al.
Published: (2025-01-01)

Clinicopathological Characteristics, Treatment, and Prognosis of 21 Patients with Primary Gastric Squamous Cell Carcinoma
by: Yang Chen, et al.
Published: (2016-01-01)

Clinicopathological and Prognostic Characteristics of Malaysian Triple Negative Breast Cancer Patients Undergoing TAC Chemotherapy Regimen
by: Ahmad Aizat Abdul Aziz, et al.
Published: (2020-01-01)

The prognosis and metabolite changes of NSCLC patients receiving first‐line immunotherapy combined chemotherapy in different M1c categories according to 9th edition of TNM classification
by: Liang Zheng, et al.
Published: (2024-09-01)

The effect of baseline versus early glucocorticoid use on immune checkpoint inhibitor efficacy in patients with advanced NSCLC
by: Yifan Wang, et al.
Published: (2025-01-01)

Outcomes of Pembrolizumab plus chemotherapy for patients with metastatic non-squamous NSCLC: Real-world evidence
by: Irina Surovtsova, et al.
Published: (2025-12-01)

Tumor Location Correlates with Clinicopathological Features and Prognosis of the Solid Pseudopapillary Neoplasm
by: Zibo Meng, et al.
Published: (2018-01-01)

PD-L1 Immunohistochemistry Comparability and Their Correlation with Clinical Characteristics in NSCLC
by: Chiao-En Wu, et al.
Published: (2020-01-01)

The prognostic value of the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in colorectal cancer and colorectal anastomotic leakage patients: a retrospective study
by: Nuo Xu, et al.
Published: (2025-02-01)

Impact of Obesity on Clinicopathologic Characteristics and Disease Prognosis in Pre- and Postmenopausal Breast Cancer Patients: A Retrospective Institutional Study
by: Nehad M. Ayoub, et al.
Published: (2019-01-01)

Predictive Value of CCTA Plaque Characteristics for the Progression and Prognosis of Coronary Artery Stenosis
by: Zhengteng LI, et al.
Published: (2025-01-01)

Clinicopathological features and prognosis of cervical adenosarcoma: A study based on the SEER database
by: Yue-yuan Geng
Published: (2025-02-01)

Immune Checkpoint Inhibitors +/− Chemotherapy for Patients With NSCLC and Brain Metastases: A Systematic Review and Network Meta‐Analysis
by: Lauren Julia Brown, et al.
Published: (2025-01-01)

Clinicopathological Characteristics and Prognosis of Upper Gastric Cancer Patients in China: A 32-Year Single-Center Retrospective Clinical Study
by: Yingbo Gong, et al.
Published: (2019-01-01)

PLR (Plastic Lithium Rechargeable) Batteries Using Nanoscale Materials: A Convenient Electrical Energy Power for the Future?
by: G. Campet, et al.
Published: (1999-01-01)

SPOP Inhibition of Endometrial Carcinoma and Its Clinicopathological Relationship
by: Qing Zhu, et al.
Published: (2022-01-01)

Gut microbial subtypes and clinicopathological value for colorectal cancer
by: Shuwen Han, et al.
Published: (2024-09-01)

Corrigendum to “Clinicopathological Characteristics and Prognosis of Papillary Thyroid Carcinoma in Naturally Menopausal Women with Various Durations of Premenarche, Reproductive Periods, and Postmenopausal Stages”
by: Xu-Hang Zhu, et al.
Published: (2018-01-01)

Case report: Personalized management of treatment resistance in advanced NSCLC patients with mutated epidermal growth factor receptor: special examples and literature review
by: Jun Wang, et al.
Published: (2025-02-01)

Efficacy and Safety of Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting Transforming Growth Factor-β and Programmed Death-Ligand 1, Plus Chemotherapy in Patients With Stage IV NSCLC
by: Christian Rolfo, MD, PhD, et al.
Published: (2025-01-01)

Immunohistochemical subtypes and their relationship with the clinicopathological and histological aspects of breast cancer
by: Lourdes González-Longoria Boada, et al.
Published: (2022-05-01)

Comparative analysis of alectinib and brigatinib in real-world treatment of advanced NSCLC with ALK rearrangements
by: Kyuhwan Kim, et al.
Published: (2025-02-01)

Exploring the efficacy of fluorouracil and platinum based chemotherapy in advanced hepatocellular carcinoma to bridge the treatment gap in resource limited settings
by: Se Jun Park, et al.
Published: (2025-01-01)

Malignant Peritoneal Mesothelioma: Clinicopathological Characteristics of Two Cases
by: Mustafa Cem Algın, et al.
Published: (2014-01-01)

Papillary Carcinoma of Breast: Clinicopathological Characteristics, Management, and Survival
by: Bushra Rehman, et al.
Published: (2022-01-01)

Clinical characteristics of EGFR-ctDNA shedders in EGFR-mutant NSCLC patients
by: Martina Ruglioni, et al.
Published: (2025-02-01)

Cost-effectiveness analysis of gumarontinib versus savolitinib for the treatment of advanced or metastatic NSCLC with MET exon 14 skipping mutations in China using partitioned survival model
by: Gang Fang, et al.
Published: (2025-01-01)

Retracted: Detection and Significance of Cell-Free DNA Mutation in Pleural Effusion in Patients with Advanced NSCLC
by: Emergency Medicine International
Published: (2024-01-01)

The value of inflammation-related indicators in chemotherapy efficacy and disease-free survival of triple-negative breast cancer
by: Jie Zhu, et al.
Published: (2025-02-01)

Clinicopathological Features, Treatment Strategy, and Prognosis of Primary Non-Hodgkin’s Lymphoma of the Duodenum: A SEER Database Analysis
by: Guoliang Zheng, et al.
Published: (2020-01-01)

Giant Cell Reparative Granuloma of the Orbit: Clinicopathological Characteristics and Treatment
by: Álvaro Bengoa-González, et al.
Published: (2021-01-01)

The Clinicopathological Characteristics and Prognoses of dMMR Gastric Adenocarcinoma Patients
by: Jie Wang, et al.
Published: (2021-01-01)

Clinicopathological characteristics and gene mutations in 11 patients with lipoprotein glomerulopathy
by: Yan Qin, et al.
Published: (2024-12-01)

Immune microenvironment features underlying the superior efficacy of neoadjuvant immunochemotherapy over chemotherapy in local advanced gastric cancer
by: Ning Zhang, et al.
Published: (2025-01-01)

Clinical Utility of Combined Tissue and Plasma Next-Generation Sequencing in Patients With Advanced, Treatment-Naïve NSCLC
by: Helena Bote-de Cabo, MD, et al.
Published: (2025-03-01)

Brigatinib treatment in a patient with advanced NSCLC with XPO1-ALK fusion: a case report
by: Yang Zhang, et al.
Published: (2025-01-01)

Clinicopathological characteristics and long-term prognosis of triple-negative breast cancer patients with HER2-Low expression: a retrospective propensity score-matched cohort study
by: Xin Liu, et al.
Published: (2024-12-01)

Electrocardiographic Characteristics of Breast Cancer Patients Treated with Chemotherapy
by: Xufei Liang, et al.
Published: (2020-01-01)